Antipsychotic medication for behaviors that challenge in individuals with intellectual disabilities: a clinically informed review
Individuals with intellectual disabilities (ID) frequently exhibit behaviors that challenge (BC), such as aggression and self-injury, which significantly impact their quality of life. Pharmacological interventions, particularly antipsychotics, are regularly employed to manage these behaviors. Howeve...
Saved in:
| Main Authors: | Alessandro Pascucci, Fabienne Gerber, Marie Besson, Markus Kosel |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-07-01
|
| Series: | Frontiers in Psychiatry |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fpsyt.2025.1609408/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Deterioration of COVID-19 vaccine efficacy by antipsychotic medications in schizophrenia patients
by: Takashi Kusunoki, et al.
Published: (2025-05-01) -
The impact of aripiprazole on neurocognitive function in individuals at clinical high risk for psychosis: A comparison with olanzapine and non-antipsychotic treatment
by: JiaHui Zeng, et al.
Published: (2025-01-01) -
METHODS ELABORATION ON DETECTION OF SOME ATYPICAL NEUROLYTIC AGENTS FOR CHEMICAL AND TOXICOLOGICAL ANALYSIS
by: I. P. Remezova, et al.
Published: (2015-09-01) -
An initial step toward symptom-based pharmacotherapy for borderline personality disorder: a systematic review and meta-analysis
by: Ramin Abdi Dezfouli, et al.
Published: (2025-08-01) -
Comparative cardiovascular outcomes of aripiprazole vs. risperidone in patients with type 2 diabetes and schizophrenia: a retrospective cohort study
by: Yi-Ting Yeh, et al.
Published: (2025-07-01)